ArticleCurrent pharmaceutical design2026
Black Oat (
Article in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAvena strigosa offers exceptional nutritional value and digestibility for cattle feed, and its seeds have cosmetic and food industry applications. This research aims to explore the phytochemicals and pharmacological potential of its seeds against diabetes.
methodsThe phytoconstituents of Avena strigosa (AS) seeds were evaluated through different analytical techniques. Methanolic extract and its fractions were tested for antioxidant and antidiabetic activities.
resultsThe qualitative analyses validated the existence of terpenoids, saponins, flavonoids, alkaloids, phenolics, tannins, reducing sugars, and cardiac glycosides. Proximate composition revealed components in g/100g, i.e., moisture, ash, crude fiber, crude fat, crude protein, and nitrogen-free extract, while elemental study detected K DISCUSSION: AS seeds exhibit antioxidant effects through their phenolic and flavonoid content, while also inhibiting α-amylase and α-glucosidase, thereby controlling hyperglycemia effectively.
conclusionAS seeds are nutrient-rich and contain bioactive compounds that can promote health and combat diseases, such as oxidative stress and diabetes.
Indexed as
Identifiers
42483916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.